Looking at the clinical data of dogs presenting with CD5+ B-cell lymphoma, the age at diagnosis appears higher than in dogs without this phenotypic aberrancy (median 12.5 and 8 years, respectively; Figure 3 and Supplementary Table S4). This evidence concerns the gene CD5 and B-cell non-Hodgkin lymphoma.